Garrie Richardson - 19 Oct 2023 Form 3 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role: Chief Revenue Officer
Signature: /s/ Garrie Richardson
Issuer symbol: BLFS
Transactions as of: 19 Oct 2023
Net transactions value: $0
Form type: 3
Filing time: 01 Nov 2023, 17:29:29 UTC
Next filing: 12 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BLFS	Common Stock						69,007	19 Oct 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BLFS	Restricted Stock Award							19 Oct 2023	Common Stock	36,320	$0.000000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The amount represented in Column 2 of Table I includes 69,007 shares of the Company's restricted stock granted on October 1, 2020 pursuant to the BioLife Solutions 2013 Performance Incentive Plan, as amended (the "Plan"), which vests in equal quarterly installments.
F2	The restricted stock was granted pursuant to the 2023 Omnibus Performance Incentive Plan. The restricted stock will vest 25% on the first anniversary of the grant date and thereafter annually in four equal installments. The restricted stock was granted to the reporting person as a part of their appointment to the position of Chief Revenue Officer.